213 related articles for article (PubMed ID: 20089869)
1. Treatment of sheep steroid-induced ocular hypertension with a glucocorticoid-inducible MMP1 gene therapy virus.
Gerometta R; Spiga MG; Borrás T; Candia OA
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3042-8. PubMed ID: 20089869
[TBL] [Abstract][Full Text] [Related]
2. Development of a gene therapy virus with a glucocorticoid-inducible MMP1 for the treatment of steroid glaucoma.
Spiga MG; Borrás T
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3029-41. PubMed ID: 20089870
[TBL] [Abstract][Full Text] [Related]
3. Suppression of corticosteroid-induced ocular hypertension in sheep by anecortave.
Candia OA; Gerometta R; Millar JC; Podos SM
Arch Ophthalmol; 2010 Mar; 128(3):338-43. PubMed ID: 20212205
[TBL] [Abstract][Full Text] [Related]
4. Steroid-induced ocular hypertension in normal sheep.
Gerometta R; Podos SM; Danias J; Candia OA
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):669-73. PubMed ID: 18824726
[TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator reduces the elevated intraocular pressure induced by prednisolone in sheep.
Candia OA; Gerometta RM; Danias J
Exp Eye Res; 2014 Nov; 128():114-6. PubMed ID: 25304217
[TBL] [Abstract][Full Text] [Related]
6. Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection.
Yamamoto Y; Komatsu T; Koura Y; Nishino K; Fukushima A; Ueno H
Can J Ophthalmol; 2008 Feb; 43(1):42-7. PubMed ID: 18204501
[TBL] [Abstract][Full Text] [Related]
7. Reduction of steroid-induced intraocular pressure elevation in sheep by tissue plasminogen activator.
Gerometta R; Kumar S; Shah S; Alvarez L; Candia O; Danias J
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):7903-9. PubMed ID: 24176900
[TBL] [Abstract][Full Text] [Related]
8. Steroid-induced ocular hypertension in normal cattle.
Gerometta R; Podos SM; Candia OA; Wu B; Malgor LA; Mittag T; Danias J
Arch Ophthalmol; 2004 Oct; 122(10):1492-7. PubMed ID: 15477461
[TBL] [Abstract][Full Text] [Related]
9. Inducible scAAV2.GRE.MMP1 lowers IOP long-term in a large animal model for steroid-induced glaucoma gene therapy.
Borrás T; Buie LK; Spiga MG
Gene Ther; 2016 May; 23(5):438-49. PubMed ID: 26855269
[TBL] [Abstract][Full Text] [Related]
10. Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
Sallam A; Sheth HG; Habot-Wilner Z; Lightman S
Am J Ophthalmol; 2009 Aug; 148(2):207-213.e1. PubMed ID: 19403113
[TBL] [Abstract][Full Text] [Related]
11. Reduction of intraocular pressure with anecortave acetate in eyes with ocular steroid injection-related glaucoma.
Robin AL; Suan EP; Sjaarda RN; Callanan DG; Defaller J;
Arch Ophthalmol; 2009 Feb; 127(2):173-8. PubMed ID: 19204235
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Bozkurt E; Kara N; Yazici AT; Yuksel K; Demirok A; Yilmaz OF; Demir S
Am J Ophthalmol; 2011 Dec; 152(6):976-981.e2. PubMed ID: 21861972
[TBL] [Abstract][Full Text] [Related]
13. The effect of selective laser trabeculoplasty on intraocular pressure in patients with intravitreal steroid-induced elevated intraocular pressure.
Rubin B; Taglienti A; Rothman RF; Marcus CH; Serle JB
J Glaucoma; 2008; 17(4):287-92. PubMed ID: 18552614
[TBL] [Abstract][Full Text] [Related]
14. Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant.
Parekh A; Srivastava S; Bena J; Albini T; Nguyen QD; Goldstein DA
JAMA Ophthalmol; 2015 May; 133(5):568-73. PubMed ID: 25719937
[TBL] [Abstract][Full Text] [Related]
15. Anterior Migration of Triamcinolone Acetonide after Posterior Subtenon Injection for Macular Edema Predisposes to Intraocular Pressure Elevation.
Yang YH; Hsu WC; Hsieh YT
Curr Eye Res; 2021 May; 46(5):689-693. PubMed ID: 32985270
[TBL] [Abstract][Full Text] [Related]
16. The effect of intravitreal triamcinolone acetonide on intraocular pressure.
Bakri SJ; Beer PM
Ophthalmic Surg Lasers Imaging; 2003; 34(5):386-90. PubMed ID: 14509462
[TBL] [Abstract][Full Text] [Related]
17. Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study.
Inatani M; Iwao K; Kawaji T; Hirano Y; Ogura Y; Hirooka K; Shiraga F; Nakanishi Y; Yamamoto H; Negi A; Shimonagano Y; Sakamoto T; Shima C; Matsumura M; Tanihara H
Am J Ophthalmol; 2008 Apr; 145(4):676-681. PubMed ID: 18243153
[TBL] [Abstract][Full Text] [Related]
18. The relationship between plasma MMP-9 and TIMP-2 levels and intraocular pressure elevation in diabetic patients after intravitreal triamcinolone injection.
Yildirim N; Sahin A; Erol N; Kara S; Uslu S; Topbas S
J Glaucoma; 2008; 17(4):253-6. PubMed ID: 18552607
[TBL] [Abstract][Full Text] [Related]
19. Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes.
Hirano Y; Ito T; Nozaki M; Yasukawa T; Sakurai E; Yoshida M; Ogura Y
Jpn J Ophthalmol; 2009 Sep; 53(5):519-22. PubMed ID: 19847609
[TBL] [Abstract][Full Text] [Related]
20. Mutant human myocilin induces strain specific differences in ocular hypertension and optic nerve damage in mice.
McDowell CM; Luan T; Zhang Z; Putliwala T; Wordinger RJ; Millar JC; John SW; Pang IH; Clark AF
Exp Eye Res; 2012 Jul; 100():65-72. PubMed ID: 22575566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
